Global diagnostic company, Anbio Biotechnology (NNNN) priced its initial public offering of 1.6M shares at $5.00 per share. The Class A ordinary shares have been approved for listing on the Nasdaq ...

Anbio Biotechnology, a global medical technology company focused on in vitro diagnostics, has successfully closed its initial public offering of 1,600,000 Class A ordinary shares at a price of $5. ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

09:59 EDT Anbio Biotechnology (NNNN) trading halted, volatility trading pause Effectively assess a stock's risks and opportunities with a clear breakdown of its positive and negative factors.

Write to [email protected] Anbio Biotechnology Registered NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

In this dynamic environment, identifying small-cap stocks like Anbio Biotechnology that possess strong growth potential and innovative capabilities can offer intriguing opportunities for investors ...

NasdaqCM:ICG Debt to Equity as at Mar 2025 Overview: Anbio Biotechnology specializes in providing in vitro diagnostics (IVD) products globally, with a market cap of $331.82 million. Operations ...

In this dynamic environment, identifying small-cap stocks like Anbio Biotechnology that possess strong growth potential and innovative capabilities can offer intriguing opportunities for investors ...